Edwards Lifesciences Corporation Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net
Edwards Lifesciences Corporation (EW) reported Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net of $85.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss · last filed 2026-08-04
- Edwards Lifesciences Corporation business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for the quarter ending 2026-06-30 was $19.90M.
- Edwards Lifesciences Corporation business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for the quarter ending 2026-03-31 was $65.20M.
- Edwards Lifesciences Corporation business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Edwards Lifesciences Corporation business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for the quarter ending 2025-09-30 was $0.00.
- Edwards Lifesciences Corporation business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Edwards Lifesciences Corporation business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for fiscal 2024 was $55.00M.
- Edwards Lifesciences Corporation business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for fiscal 2023 was $0.00.
- Edwards Lifesciences Corporation business combination, step acquisition, equity interest in acquiree, remeasurement gain (loss), net for fiscal 2022 was $0.00.
| Period end | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net 3 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net 6 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net 9 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $85.10M 10-Q · filed 2026-08-04 | $85.10M derived: sum of 3 quarters · filed 2026-08-04 | $85.10M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $65.20M 10-Q · filed 2026-05-06 | $65.20M derived: sum of 2 quarters · filed 2026-05-06 | $65.20M derived: sum of 3 quarters · filed 2026-05-06 | $65.20M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | $0.00 10-K · filed 2026-02-25 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2026-08-04 | $0.00 10-Q · filed 2025-11-05 | $30.40M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | $30.40M derived: sum of 3 quarters · filed 2026-08-04 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-06 | $30.40M derived: sum of 2 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $30.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $55.00M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $24.60M 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-06 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |